Why GLP-1 Costs Are a Symptom, Not the Disease
Employers are scrambling to manage GLP-1 drug costs, but the real question is why metabolic disease has become so prevalent in the workforce — and what to do about it.
Read MoreJames M. Knox writes at the intersection of human health, business strategy, and the decisions that shape how we live and work.
How Employers Can Win the Metabolic Health Crisis
The Health Dividend is a complete framework for metabolic health written in the language of the investment principles you already use every day. Nutrition, muscle, movement, sleep, hormones, inflammation, and the modern tools of precision medicine are not wellness recommendations. They are deposits. They compound. They produce returns that show up in your energy, your presence, your productivity, and the quality of every year you live.
A Simple Framework for Sustainable Metabolic Health
A practical, evidence-informed approach to building metabolic health habits that stick — without extreme diets or unsustainable programs.
2026 Baseline Edition — Annual Policy Report
An independent annual reference report on the prevalence, cost, and policy landscape of metabolic disease across Medicaid, Medicare, and employer-sponsored health coverage in the United States.
Employers are scrambling to manage GLP-1 drug costs, but the real question is why metabolic disease has become so prevalent in the workforce — and what to do about it.
Read MoreThere's a smarter way to offer metabolic health support to employees — one that doesn't expose the medical plan to open-ended liability.
Read MoreWeight is a proxy. The Metabolic Health Index was built to track the indicators that actually predict long-term health outcomes.
Read MoreJames M. Knox has spent decades at the intersection of employee benefits, business strategy, and human health. He founded HealthDividend360 to solve a problem he kept seeing: employers caught between employee demand for modern healthcare and the financial reality of covering it.
His writing draws on real-world experience advising large employers and brokers — translating complex benefit strategy into ideas that are clear, actionable, and worth your time.
Read the Full StoryNew essays on health, business, and strategy — delivered when they're ready, not on a schedule.